US FDA approves Merck’s Ebola vaccine for under-18s
Pharmaceutical Technology
AUGUST 4, 2023
The US FDA has granted approval for an expanded indication of Merck’s Ebola vaccine, Ervebo, for usage in the paediatric population.
Sat.Jul 29, 2023 - Fri.Aug 04, 2023
246 
Moderna looks to new COVID booster, RSV shot to curb falling sales
Bio Pharma Dive
AUGUST 3, 2023
Sales of the company’s COVID-19 vaccine plummeted 94% year over year. But executives believe newer products can help revenue rebound.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Experimental Alzheimer’s Vaccine Shown to Delay Symptoms in Mice
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 3, 2023
An experimental vaccine that aims to slow down or prevent the progression of Alzheimer’s disease has been trialed in mice with promising early results. Mice engineered with genes that put them at greater risk of an Alzheimer’s-like disease had fewer amyloid plaques following the vaccine.
Swimming with the Sharks: Translation of Pragmatic Trial Results
Rethinking Clinical Trials
AUGUST 4, 2023
Swimming with the Sharks: Translation of Pragmatic Trial Results Description Dr. Greg Simon discussing translating pragmatic clinical trial results. Biography Gregory Simon, MD, MPH Senior Investigator, Kaiser Permanente Washington Health Research Institute SPOT Demonstration Project PI Health Care Systems Interactions Core Chair Related View more content from the Disseminating, Implementing, and Sustaining Evidence-Based Practices into Clinical Care: NIH-Hosted Workshop.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Generative AI has the potential to revolutionise drug discovery
Pharmaceutical Technology
AUGUST 3, 2023
The impact of artificial intelligence has been profoundly felt in the drug discovery space, with increased interest in AI in recent years.
Amgen says KRAS drug met goal in late-stage colon cancer trial
Bio Pharma Dive
AUGUST 3, 2023
The company disclosed the study result alongside second quarter earnings showing Lumakras sales were flat versus the same period one year prior.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
August 3, 2023: NCI’s David Chambers Discusses Role of Implementation Science in Pragmatic Research
Rethinking Clinical Trials
AUGUST 3, 2023
This year’s Annual Steering Committee Meeting for the NIH Pragmatic Trials Collaboratory featured implementation science as one of the topics of focus. In an interview after his keynote presentation, Dr. David Chambers, deputy director for implementation science at the National Cancer Institute, shared his thoughts on opportunities for implementation science in the context of pragmatic trials.
FDA warns of reduced efficacy for oral birth control pill Tydemy
Pharmaceutical Technology
AUGUST 2, 2023
Two lots of Lupin’s Tydemy have been recalled due to a decrease in ascorbic acid levels leading to reduced effectiveness.
Steve Jobs’ son raises $200M for cancer-focused venture fund
Bio Pharma Dive
AUGUST 2, 2023
Yosemite is one of a new class of biotech venture funds that also includes the recently launched Dimension and Cure Ventures.
Scientists Discover a New, Unexpected Way That Cancer Cells Spread
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 30, 2023
One of the challenges in treating cancer is stopping it from metastasizing, and a new study reveals one of the fundamental mechanisms through which this happens. Now we know about this mechanism, perhaps we can stop it. Key to this newly discovered process is GRP78, and it’s what’s known as a chaperone protein.
August 2, 2023: Want to Play a Game? AI and Machine Learning in This Week’s PCT Grand Rounds
Rethinking Clinical Trials
AUGUST 2, 2023
Dr. Eric Perakslis In this Friday’s PCT Grand Rounds, Eric Perakslis of Duke University will present “AI & ML: Want to Play a Game?” The Grand Rounds session will be held on Friday, August 4, 2023, at 1:00 pm eastern. Bergstrom is a professor in population health sciences and the chief research technology strategist in the Duke University School of Medicine.
BioNTech acquires tech company InstaDeep for $549m
Pharmaceutical Technology
AUGUST 1, 2023
BioNTech has acquired all the remaining shares of technology company InstaDeep in a deal valued at €500m ($549m) in cash.
A once buzzy gene therapy startup lays off staff and shuts down
Bio Pharma Dive
AUGUST 2, 2023
Intergalactic, a developer of non-viral gene therapies built by ex-Biogen executive Michael Ehlers, is folding less than two years after its launch.
Living a Varied Life Boosts Brain Connectivity in Mice
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 2, 2023
The brains in mice benefit from an active and varied lifestyle by forming enhanced neural connections.Researchers in Germany compared the brain activity of mice raised in different environments and found those raised in an ‘enriched’ environment had more activity in their hippocampus, suggesting the presence of a more robust and connected neural network.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
August 1, 2023: NIH Collaboratory Expands LinkedIn Presence to Join Growing Community of Researchers
Rethinking Clinical Trials
AUGUST 1, 2023
From left: NIH Collaboratory Coordinating Center co–principal investigators Lesley Curtis, Adrian Hernandez, and Kevin Weinfurt With the NIH Pragmatic Trials Collaboratory entering its second decade, we are expanding our presence on the LinkedIn social media platform to promote research that advances the design, conduct, and dissemination of pragmatic clinical trials.
Removing snags in cell and gene therapy manufacturing processes with robotics
Pharmaceutical Technology
JULY 31, 2023
Deploying robots in pharmaceutical manufacturing will remove snags in cell and gene therapies and enable breakthroughs
Sarepta offers early look at closely watched gene therapy launch
Bio Pharma Dive
AUGUST 3, 2023
One patient received its Duchenne gene therapy, Elevidys, this week and a handful more could follow shortly, surprising some analysts and raising near-term sales expectations.
DoP rejects Zydus’ review petition against NPPA for fixing retail price of sitagliptin-metformin combo
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 2, 2023
In a significant decision, the Department of Pharmaceuticals (DoP) has rejected a review petition filed by Zydus Healthcare against the National Pharmaceutical Pricing Authority (NPPA) for fixing the retail price of anti-diabetic combination formulation comprising sitagliptin and metformin, observing that while the NPPA has not acted strictly by the books, it protected the public interest.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
July 31, 2023: NIH Announces Funding Opportunity for Pain Management Collaboratory Pragmatic Trials
Rethinking Clinical Trials
JULY 31, 2023
The NIH this month published notice of a funding opportunity to support the next round of pragmatic clinical trials within the NIH-DoD-VA Pain Management Collaboratory (PMC). Read the full notice of funding opportunity (RFA-AT-24-004). The PMC was established in 2017 with an initial cohort of 11 pragmatic trials. The new funding opportunity leverages the experience, expertise, and leadership of the PMC Coordinating Center with a new round of pragmatic trials evaluating nonpharmacologic solutions
Personalised mRNA cancer vaccines: Moderna and Merck & Co versus BioNTech and Roche
Pharmaceutical Technology
JULY 31, 2023
While messenger ribonucleic acid (mRNA)-based cancer vaccines have been in development for decades, their development had languished.
BridgeBio explores path forward for muscular disease drug
Bio Pharma Dive
JULY 31, 2023
According to the company, FDA officials have signaled openness to using a surrogate endpoint for assessing accelerated approval of a treatment for limb-girdle muscular dystrophy.
Industry concerned over lack of discussion on proposed New Drugs, Medical Devices & Cosmetics Bill
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 30, 2023
Even as the Centre has listed the New Drugs, Medical Devices and Cosmetics Bill, 2023 to be tabled in Parliament during the current session, industry members are apprehensive that the new bill may mean centralisation of licensing and other powers to the Central drug regulatory authority and it may also have provisions which may harm […]
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Partnership aims to boost mental health research
Pharma Times
AUGUST 2, 2023
The University of Strathclyde, the NHS and New York University join forces to increase knowledge - News - PharmaTimes
Bangladesh and the dengue vaccine question
Pharmaceutical Technology
AUGUST 4, 2023
Amid one of the worst dengue fever outbreaks in decades, Bangladesh has recorded the highest number of hospitalised cases of the disease in a day.
Regeneron gets ‘clarity’ in plan to defend top-selling eye drug, but is set back elsewhere
Bio Pharma Dive
AUGUST 4, 2023
The surprise rejection of a high-dose form of Eylea could be resolved earlier than anticipated. But some of the company’s pipeline projects have stumbled.
IISc researchers find picolinic acid’s broad-spectrum antiviral abilities, scouts for partners in pharma companies
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 3, 2023
Researchers at the Indian Institute of Science (IISc) have found that picolinic acid, a natural compound produced by mammalian cells, can block several disease-causing viruses such as SARS-CoV-2 and influenza A viruses. The Institute is now looking for partners in pharma companies to pursue further clinical development of the findings.
First patient dosed in Immutep’s soft tissue sarcoma trial
Pharma Times
JULY 31, 2023
The phase 2 study involves company’s eftilagimod alpha therapy - News - PharmaTimes
Rx Machina: How AI is transforming pharma sales
Pharmaceutical Technology
JULY 31, 2023
Pharma sales have undergone a seismic transformation after Covid-19, with the adoption of artificial intelligence tools.
RSV antibody from Sanofi, AstraZeneca backed by CDC for use in infants
Bio Pharma Dive
AUGUST 4, 2023
The treatment, which won FDA approval in July, is expected to be available by the start of the typical RSV season this fall.
India’s advanced wound care market on growth trajectory with faster healing & minimised scarring
AuroBlog - Aurous Healthcare Clinical Trials blog
AUGUST 1, 2023
India’s advanced wound care market is on the growth trajectory with faster healing & minimised scarring. This is where the positive acceptance of Negative Pressure Wound Therapy (NPWT) that uses a vacuum dressing to ensure healing in acute and chronic conditions in India is gaining popularity.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content